Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Author:

Filho Otto Metzger1,Stover Daniel G.23,Asad Sarah3,Ansell Peter J.4,Watson Mark5,Loibl Sibylle6,Geyer Charles E.78,Bae Junu2,Collier Katharine23,Cherian Mathew234,O’Shaughnessy Joyce9,Untch Michael10,Rugo Hope S.11,Huober Jens B.1213,Golshan Mehra141516,Sikov William M.17,von Minckwitz Gunter6,Rastogi Priya18,Maag David4,Wolmark Norman19,Denkert Carsten20,Symmans W. Fraser21

Affiliation:

1. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

2. Department of Medicine, The Ohio State University College of Medicine, Columbus

3. Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus

4. AbbVie, Inc, North Chicago, Illinois

5. Washington University, St Louis, Missouri

6. German Breast Group, Neu-Isenburg, Germany

7. Massey Cancer Center, Virginia Commonwealth University, Richmond

8. Now with Houston Methodist Cancer Center, Houston, Texas

9. Texas Oncology–Baylor Charles A. Sammons Cancer Center, Dallas

10. Helios Klinikum Berlin-Buch, Berlin, Germany

11. University of California, San Francisco

12. University Medical Center Ulm, Ulm, Germany

13. Now with Department of Interdisciplinary Medical Services, Breast Center, Cantonal Hospital St Gallen, St Gallen, Switzerland.

14. Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts

15. Breast Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts

16. Now with Yale Cancer Center, New Haven, Connecticut

17. Women and Infants Hospital of Rhode Island, Providence

18. University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, Pennsylvania

19. Allegheny General Hospital, Pittsburgh, Pennsylvania

20. Institute of Physiology and Pathophysiology, Department of Medicine, Philipps-University Marburg and University Hospital of Giessen and Marburg, Marburg, Germany

21. The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3